Works matching IS 03407004 AND DT 2007 AND VI 56 AND IP 9
Results: 16
Density of DC-LAMP<sup>+</sup> mature dendritic cells in combination with activated T lymphocytes infiltrating primary cutaneous melanoma is a strong independent prognostic factor.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 9, p. 1459, doi. 10.1007/s00262-007-0286-3
- By:
- Publication type:
- Article
Expansion and characteristics of human T regulatory type 1 cells in co-cultures simulating tumor microenvironment.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 9, p. 1429, doi. 10.1007/s00262-007-0280-9
- By:
- Publication type:
- Article
A new epitope peptide derived from hepatitis C virus 1b possessing the capacity to induce cytotoxic T-lymphocytes in HCV1b-infected patients with HLA-A11, -A31, and -A33.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 9, p. 1359, doi. 10.1007/s00262-007-0284-5
- By:
- Publication type:
- Article
Increase in CD30 ligand/CD153 and TNF-α expressing mast cells in basal cell carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 9, p. 1407, doi. 10.1007/s00262-007-0290-7
- By:
- Publication type:
- Article
Dendritic cells loaded with polyomavirus VP1/VP2Her2 virus-like particles efficiently prevent outgrowth of a Her2/neu expressing tumor.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 9, p. 1335, doi. 10.1007/s00262-007-0281-8
- By:
- Publication type:
- Article
Adoptive therapy of head and neck squamous cell carcinoma with antibody coated immune cells: a pilot clinical trial.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 9, p. 1397, doi. 10.1007/s00262-007-0283-6
- By:
- Publication type:
- Article
The Thomsen-Friedenreich disaccharide as antigen for in vivo tumor targeting with multivalent scFvs.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 9, p. 1345, doi. 10.1007/s00262-007-0292-5
- By:
- Publication type:
- Article
Long-term immunity elicited by antibody–cytokine fusion proteins protects against sequential challenge with murine mammary and colon malignancies.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 9, p. 1507, doi. 10.1007/s00262-007-0297-0
- By:
- Publication type:
- Article
Development of anti-PAX3 immune responses; a target for cancer immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 9, p. 1381, doi. 10.1007/s00262-007-0294-3
- By:
- Publication type:
- Article
The combined activation of positive costimulatory signals with modulation of a negative costimulatory signal for the enhancement of vaccine-mediated T-cell responses.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 9, p. 1471, doi. 10.1007/s00262-007-0291-6
- By:
- Publication type:
- Article
Reciprocal effects of Th1 and Treg cell inducing pathogen-associated immunomodulatory molecules on anti-tumor immunity.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 9, p. 1367, doi. 10.1007/s00262-007-0288-1
- By:
- Publication type:
- Article
Interleukin 21 therapy increases the density of tumor infiltrating CD8<sup>+ </sup>T cells and inhibits the growth of syngeneic tumors.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 9, p. 1417, doi. 10.1007/s00262-007-0285-4
- By:
- Publication type:
- Article
Vaccination with p53 peptide-pulsed dendritic cells is associated with disease stabilization in patients with p53 expressing advanced breast cancer; monitoring of serum YKL-40 and IL-6 as response biomarkers.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 9, p. 1485, doi. 10.1007/s00262-007-0293-4
- By:
- Publication type:
- Article
No evidence for circulating HuD-specific CD8<sup>+</sup> T cells in patients with paraneoplastic neurological syndromes and Hu antibodies.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 9, p. 1501, doi. 10.1007/s00262-007-0295-2
- By:
- Publication type:
- Article
Induction of protective immune responses against NXS2 neuroblastoma challenge in mice by immunotherapy with GD2 mimotope vaccine and IL-15 and IL-21 gene delivery.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 9, p. 1443, doi. 10.1007/s00262-007-0289-0
- By:
- Publication type:
- Article
Role of IL-21 in immune-regulation and tumor immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 9, p. 1323, doi. 10.1007/s00262-007-0326-z
- By:
- Publication type:
- Article